Abstract
Medical management of peripheral arterial disease (PAD) patients is aimed at limb symptom relief and reducing systemic major adverse events risk. For the first purpose: exercise therapy is recommended in case of claudication; multidisciplinary evaluation for surgical options is mandatory in case of critical limb ischaemia. Reducing cardiac and stroke risk can be achieved through: statin prescription in most of the cases; antiplatelet agents in symptomatic PAD patients; cardio-vascular risk factors control.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Arteriosclerosis Obliterans / drug therapy
-
Disease Management
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Intermittent Claudication / drug therapy
-
Ischemia / drug therapy
-
Ischemia / surgery
-
Leg / blood supply*
-
Patient Education as Topic
-
Peripheral Arterial Disease / complications
-
Peripheral Arterial Disease / drug therapy*
-
Peripheral Arterial Disease / surgery
-
Platelet Aggregation Inhibitors / therapeutic use
-
Risk Factors
-
Stroke / prevention & control
-
Thrombophilia / drug therapy
-
Thrombophilia / etiology
-
Vascular Grafting / methods
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Platelet Aggregation Inhibitors